Patients with localized juvenile periodontitis (LJP) have elevated levels of immunoglobulin G2 (IgG2) in their sera. This is also observed in vitro when peripheral blood leukocytes from LJP patients are stimulated with pokeweed mitogen. In previous studies, we showed that lymphocytes from subjects with no periodontitis (NP subjects) produced substantial amounts of IgG2 when they were cultured with monocytes from LJP patients (LJP monocytes). These observations indicate that monocytes or monocyte-derived mediators are positive regulators of the production of IgG2. The present study was initiated to determine if secreted factors from LJP monocytes were capable of enhancing IgG2 production and to determine if prostaglandin E2 (PGE 2 ), which LJP monocytes produce at elevated levels, enhances IgG2 production. Experiments in a transwell system and with monocyte-conditioned media indicated that cell-cell contact was not necessary for LJP monocytes to augment the production of IgG2 by T and B cells from NP subjects. Moreover, the production of IgG2 was selectively induced by the addition of PGE 2 or platelet-activating factor (PAF), another lipid cytokine, which can elevate PGE 2 synthesis. Furthermore, IgG2 production was abrogated when cells were treated with indomethacin, a cyclooxygenase inhibitor that blocks the synthesis of PGE 2 , or the PAF antagonists CV3988 and TEPC-15. The effects of indomethacin were completely reversed by PGE 2 , indicating that this is the only prostanoid that is essential for the production of IgG2. Similarly, PGE 2 reversed the effects of a PAF antagonist, suggesting that the effects of PAF are mediated through the induction of PGE 2 synthesis. Together, these data indicate that PGE 2 and PAF are essential for the production of IgG2.Recent results suggest that early-onset periodontitis (EOP) patients have a genetic predisposition to develop disease early in life (22). The clinical manifestations of EOP are variable. Even in the same family, some patients may have a localized form restricted to first molars and incisors (localized juvenile periodontitis [LJP]) and others a severe generalized form. It is likely that these differences in clinical expression are related to several factors, including differences in microbial flora and differences in the host response. Serum total immunoglobulin G2 (IgG2) levels in LJP patients are significantly elevated over those in race-and age-matched controls with no periodontitis (NP controls) (21). Much of this IgG2 antibody is directed against Actinobacillus actinomycetemcomitans serotype b, a putative etiologic agent for EOP, and Porphyromonas gingivalis, which is also associated with EOP (8,20,36,37). The immunodominant antigens of these organisms are the serotype-specific carbohydrates, and, for A. actinomycetemcomitans, the carbohydrate is a high-molecular-weight form of lipopolysaccharide (LPS) (7,8,35,36). Compared to NP subjects, EOP patients frequently have very high titers of IgG2 reactive with the high-molecular-weight A. actinomycetemcomita...